Literature DB >> 9214465

Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity.

L N Bull1, V E Carlton, N L Stricker, S Baharloo, J A DeYoung, N B Freimer, M S Magid, E Kahn, J Markowitz, F J DiCarlo, L McLoughlin, J T Boyle, B B Dahms, P R Faught, J F Fitzgerald, D A Piccoli, C L Witzleben, N C O'Connell, K D Setchell, R M Agostini, S A Kocoshis, J Reyes, A S Knisely.   

Abstract

Byler disease (ByD) is an autosomal recessive disorder in which cholestasis of onset in infancy leads to hepatic fibrosis and death. Children who have a clinically similar disorder, but are not members of the Amish kindred in which ByD was described, are said to have Byler syndrome (ByS). Controversy exists as to whether ByD and ByS (subtypes of progressive familial intrahepatic cholestasis [PFIC]) represent one clinicopathological entity. The gene for ByD has been mapped to a 19-cM region of 18q21-q22. PFIC caused by a lesion in this region, including ByD, can be designated PFIC-1. Examination of haplotypes in siblings with ByS in two unrelated non-Amish families showed that the gene(s) responsible for their disorder(s) did not lie in the PFIC-1 candidate region. On light microscopy and transmission electron microscopy (TEM), liver tissue differed between Amish children with PFIC-1, who had coarsely granular bile and at presentation had bland intracanalicular cholestasis, and the children with ByS in the two non-Amish families, who had amorphous or finely filamentous bile and at presentation had neonatal hepatitis. Bile acid composition of bile also differed: In the Amish children with PFIC-1 and in one ByS family, the proportional concentration of chenodeoxycholic acid (CDCA) in bile was low compared with normal bile; in the other ByS family, it was only slightly reduced. Genetic analysis and light microscopy and TEM of liver may help distinguish PFIC-1 from other forms of ByS.

Entities:  

Mesh:

Year:  1997        PMID: 9214465     DOI: 10.1002/hep.510260121

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

Review 1.  The molecular genetics of familial intrahepatic cholestasis.

Authors:  P L Jansen; M Müller
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

Review 2.  Recent advances in pediatric liver transplantation.

Authors:  Debora Kogan-Liberman; Sukru Emre; Benjamin L Shneider
Journal:  Curr Gastroenterol Rep       Date:  2002-02

3.  Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Authors:  Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Karan Emerick; Anthony Antoniou; Catherine Wanty; Bjorn Fischler; Emmanuel Jacquemin; Sami Wali; Samra Blanchard; Inge-Merete Nielsen; Billy Bourke; Shirley McQuaid; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Leo Klomp; Roderick Houwen; Peter Bacchetti; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Benjamin Shneider; Antal Nemeth; Etienne Sokal; Nelson B Freimer; A S Knisely; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson; Laura N Bull
Journal:  J Hepatol       Date:  2010-04-13       Impact factor: 25.083

4.  Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24.

Authors:  S S Strautnieks; A F Kagalwalla; M S Tanner; A S Knisely; L Bull; N Freimer; S A Kocoshis; R M Gardiner; R J Thompson
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies.

Authors:  Kimberley Evason; Kevin E Bove; Milton J Finegold; A S Knisely; Sue Rhee; Philip Rosenthal; Alexander G Miethke; Saul J Karpen; Linda D Ferrell; Grace E Kim
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

6.  Clinical utility gene card for: progressive familial intrahepatic cholestasis type 1.

Authors:  Emmanuel Gonzales; Anne Spraul; Emmanuel Jacquemin
Journal:  Eur J Hum Genet       Date:  2013-08-28       Impact factor: 4.246

Review 7.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

8.  Outcome of partial internal biliary diversion for intractable pruritus in children with cholestatic liver disease.

Authors:  P Ramachandran; N P Shanmugam; S Al Sinani; V Shanmugam; S Srinivas; M Sathiyasekaran; V Tamilvanan; M Rela
Journal:  Pediatr Surg Int       Date:  2014-07-27       Impact factor: 1.827

9.  Progressive familial intrahepatic cholestasis types 1, 2, and 3.

Authors:  P L Jansen; M M Müller
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

10.  Non-viral factors contributing to hepatocellular carcinoma.

Authors:  Manal A Hamed; Sanaa A Ali
Journal:  World J Hepatol       Date:  2013-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.